近年美国肾脏疾病的治疗方法不断改进

2015-01-12 佚名 生物谷

近日,来自美国肾脏病数据库系统的研究人员通过研究表示,尽管近年来美国肾脏疾病的发生率在逐年升高,但个体肾衰竭及相关死亡率却在不断下降。数据库中数据显示,如今在美国有14%的成年个体患有慢性肾脏疾病,其会进展成为肾衰竭。而慢性肾脏疾病的风险因子包括糖尿病、高血压、肥胖以及急性肾脏损伤等。 由于老龄化及过重人群的增加,终末期肾病的患者比率也在一直上升,据2012年的研究数据显示,在美国大


近日,来自美国肾脏病数据库系统的研究人员通过研究表示,尽管近年来美国肾脏疾病的发生率在逐年升高,但个体肾衰竭及相关死亡率却在不断下降。数据库中数据显示,如今在美国有14%的成年个体患有慢性肾脏疾病,其会进展成为肾衰竭。而慢性肾脏疾病的风险因子包括糖尿病高血压、肥胖以及急性肾脏损伤等。

由于老龄化及过重人群的增加,终末期肾病的患者比率也在一直上升,据2012年的研究数据显示,在美国大约有637000名肾衰竭病人正经历着透析以及肾脏移植,这其中包括115000名被诊断为肾衰竭的个体。

研究者表示,然而这些患者或许表现比较良好,而且生存时间更久,从2010至2012年以来潜在的致死性肾衰竭的新发病例呈直线下降,Rajiv Saran教授说道,目前我们宣布抵御肾衰竭的胜利还为时过早,但是我们的分析数据却为揭示美国肾衰竭患者的现状提供了一定的参考数据。

后期研究者们将根据此前的研究数据来观察是否肾脏疾病的发生率会持续下降,研究者们认为,一种改善肾脏健康的综合性方法或许应该包括疾病的预防以及慢性肾脏疾病相关知识的知晓;有时候患病信号不足以引起个体主义,但是简单的测试或许就可以帮助进行个体肾脏疾病的早期诊断。

推荐的新闻阅读:

Researchers at the United States Renal Data System (USRDS) say that about 14 percent of U.S. adults have chronic kidney disease, which can progress to kidney failure. Risk factors for chronic kidney disease include diabetes, high blood pressure, obesity, acute kidney injury, a family history of kidney disease, being 50 and older, and being a member of a minority.

Because of an aging and overweight population, the rate of end-stage kidney disease is on the rise, according to USRDS.

According to 2012 data, across the United States almost 637,000 kidney failure patients are undergoing dialysis or have received a kidney transplant, including about 115,000 people diagnosed with kidney failure.

However, patients may be faring better and living longer, the report's authors said. The growth rate for new cases of potentially fatal kidney failure fell for three years in a row, from 2010 to 2012, according to the 2014 annual report from the USRDS, which is based at the University of Michigan.

"It is too soon to declare victory on the war against the rising tide of kidney failure, but our analysis provides some good news about kidney disease in the U.S.," Dr. Rajiv Saran, director of the USRDS coordinating center, said in a university news release......


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=33765, encodeId=530733e65fa, content=看别人进展很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ykRSkuxjt93yc9tvDWfIQItrwiaKSCps5kyrTyDlwic2FgoCWe88wR3ZiaggKYGueDIp26zVgnbzriaQ/0, createdBy=89d71602869, createdName=sundong, createdTime=Wed Jul 29 11:22:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20262, encodeId=437b2026236, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:25:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399177, encodeId=d66a13991e775, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Wed Jan 14 00:36:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14019, encodeId=bc29140196e, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Mon Jan 12 11:47:00 CST 2015, time=2015-01-12, status=1, ipAttribution=)]
    2015-07-29 sundong

    看别人进展很重要

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=33765, encodeId=530733e65fa, content=看别人进展很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ykRSkuxjt93yc9tvDWfIQItrwiaKSCps5kyrTyDlwic2FgoCWe88wR3ZiaggKYGueDIp26zVgnbzriaQ/0, createdBy=89d71602869, createdName=sundong, createdTime=Wed Jul 29 11:22:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20262, encodeId=437b2026236, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:25:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399177, encodeId=d66a13991e775, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Wed Jan 14 00:36:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14019, encodeId=bc29140196e, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Mon Jan 12 11:47:00 CST 2015, time=2015-01-12, status=1, ipAttribution=)]
    2015-04-11 x35042875

    AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=33765, encodeId=530733e65fa, content=看别人进展很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ykRSkuxjt93yc9tvDWfIQItrwiaKSCps5kyrTyDlwic2FgoCWe88wR3ZiaggKYGueDIp26zVgnbzriaQ/0, createdBy=89d71602869, createdName=sundong, createdTime=Wed Jul 29 11:22:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20262, encodeId=437b2026236, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:25:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399177, encodeId=d66a13991e775, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Wed Jan 14 00:36:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14019, encodeId=bc29140196e, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Mon Jan 12 11:47:00 CST 2015, time=2015-01-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=33765, encodeId=530733e65fa, content=看别人进展很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=163, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3ykRSkuxjt93yc9tvDWfIQItrwiaKSCps5kyrTyDlwic2FgoCWe88wR3ZiaggKYGueDIp26zVgnbzriaQ/0, createdBy=89d71602869, createdName=sundong, createdTime=Wed Jul 29 11:22:00 CST 2015, time=2015-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20262, encodeId=437b2026236, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:25:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1399177, encodeId=d66a13991e775, content=<a href='/topic/show?id=cac364650c0' target=_blank style='color:#2F92EE;'>#治疗方法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64650, encryptionId=cac364650c0, topicName=治疗方法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cec2200006, createdName=showtest, createdTime=Wed Jan 14 00:36:00 CST 2015, time=2015-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14019, encodeId=bc29140196e, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Mon Jan 12 11:47:00 CST 2015, time=2015-01-12, status=1, ipAttribution=)]
    2015-01-12 MedSci客户端网友

    good

    0

相关资讯

清晰肾脏结构,能说出名字和功能吗?

        清晰肾脏结构,能依次的说出他们的名字和功能吗?

蔡广研:肾脏衰老:慢性肾脏病干预的新靶点

慢性肾脏病(CKD)特别是透析人群常表现出皮肤萎缩、骨质疏松、动脉硬化、认知障碍等衰老表现。青年透析患者的死亡率与老年人相当。因此,CKD是典型的早老人群。CKD肾组织学检测可见到细胞衰老表型。血管亦发生管壁增厚、硬化、顺应性下降等衰老表现,影响供血和供氧,促进肾小球硬化与肾间质纤维化,引起肾功能减退。血管老化也是CKD合并心血管并发症的重要病理基础。 CKD合并早老主要源于肾功能减退、

JASN:患肾脏疾病小鼠为何易出现心脏疾病?

根据发表在Journal of the American Society of Nephrology (JASN)杂志上一项新研究发现,血液中肾源性蛋白即所谓的Klotho蛋白水平降低会增加患肾脏疾病小鼠出现心脏疾病的风险。 如果此研究发现在临床上得到证实,那么Klotho替代疗法可能有助于保护肾功能不好患者的心脏健康。 慢性肾脏病(CKD)出现心脏疾病是死亡的主要原因。此外,心脏肥大(心脏肌

减肥手术有益于肾脏

2014年11月11日至16日在宾夕法尼亚举办的美国肾脏病学会(American Society Of Nephrology)肾病周上,来自盖辛格医学中心的研究人员通过研究表明,除了帮助病人减肥外,减肥手术或许可以帮助改善其肾脏功能。减肥手术对于病态肥胖症患者的体重减轻具有明显的作用,而病态肥胖症患者肾功能衰竭的风险往往会明显增加。目前由于减肥手术诱导的体重减轻对肾功能的效应尚不清楚,因此研究人员

全新数据显示:近年来美国肾脏疾病的治疗方法在不断改进

近日,来自美国肾脏病数据库系统的研究人员通过研究表示,尽管近年来美国肾脏疾病的发生率在逐年升高,但个体肾衰竭及相关死亡率却在不断下降。数据库中数据显示,如今在美国有14%的成年个体患有慢性肾脏疾病,其会进展成为肾衰竭。而慢性肾脏疾病的风险因子包括糖尿病、高血压、肥胖以及急性肾脏损伤等。 由于老龄化及过重人群的增加,终末期肾病的患者比率也在一直上升,据2012年的研究数据显示,在美国大约有63

stem cells:穷得要卖肾了?多养几个呗

大自然赐予我们两个肾,但你可能为了iPhone5或iPhone6少了一个,那么,面对今后随时可能出现的新产品,小伙伴们,你们的肾还够用吗?其实,无论我们曾多少次拿“卖肾赚钱”作为笑料,但当我们真正的了解肾脏移植需求和供给比率只有可怜的几十比一、或是因肾源混乱手术偷肾案件频发等等问题时,所有人的心情都会沉重下来,并不禁会想:在生物学和医学不断发展的今天,可能在体外再造自己的肾吗?日本冈山大学的研究人